Peter Geschek
Long only

HeartWare Vs. Thoratec In The Heart Pump Race

In the third quarter, HeartWare International (NASDAQ:HTWR) had better than expected sales of its cardiac pumps and as a result, its share price moved up substantially.

The jump in sales was driven by the widespread acceptance of HeartWare's HVADs (ventricular assist device), particularly in foreign markets, in line with predictions made at the time the device was launched in the U.S. a year ago.

Some predict now that HeartWare is destined to take over the leadership of the heart pump industry in the next few years from current leader, Thoratec (NASDAQ:THOR).

The company is still losing money, although the loss has narrowed to $11.4 million from $25.0 million a year ago.

In December HeartWare bought CircuLite...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details